Literature DB >> 29504848

Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.

Lara A Aqrawi1, Janicke Liaaen Jensen1, Gunnvor Øijordsbakken2, Ann-Kristin Ruus3, Ståle Nygård4,5, Marit Holden6, Roland Jonsson7,8, Hilde Kanli Galtung3, Kathrine Skarstein2,9.   

Abstract

A characteristic feature of primary Sjögren's syndrome (pSS) is the destruction of salivary and lacrimal glands mediated by mononuclear cell infiltration. Adipocytes can also occupy a large portion of the salivary gland (SG) tissue area, although little is known about their significance in pSS. We have previously investigated adipose tissue infiltration in SG biopsies from pSS patients and non-SS sicca controls. Our findings indicated the distinct incidence of adipose tissue replacement in pSS patients, where adipocytes were detected in interleukin (IL) 6 rich regions. We now aimed to examine the development of adipocytes in the SG microenvironment, and delineate their possible involvement in immune reactions. A microarray analysis was performed on SG from 6 pSS patients and 6 non-SS controls, where the expression levels of genes involved in adipose tissue development, inflammatory responses, and lymphoma development were assessed. Real-time PCR was carried out on SG from 14 pSS patients and 15 non-SS controls to account for IL6, IL10, and IL17 mRNA levels. Immunohistochemical staining of frozen SG tissue using IL17 was also conducted. Our results indicate signalling pathways identified in SG of pSS patients displayed genes leading to prominent adipose tissue development and reduced mitochondrial fatty acid beta-oxidation (ARID5B, OXCT1, BDH1, SOX8, HMGCS2, FTO, ECHS1, PCCA, ACADL and ACADVL), inflammatory responses (IL1R1, IL7R, IL10RA, IL15, IL18RAP, CCL2, CCL5, CCL22, CXCR6, CD14, and CD48), and lymphoma development via JAK-STAT signalling (STAT2, TYK2, EBI3, FAS, TNFRSF1B, MAP3K8, HMOX1, LTB, TNF, STAT1, and BAK1). Genes involved in interferon production and signalling were also detected (IRF1, IRF9, and IRF7), in addition to IL6, IL10, and IL17. Higher mRNA levels of IL6, IL17 and IL10 were observed in the SG of pSS patients compared to controls. Moreover, IL17 positive cells were detected mostly interstitially in the SG and around adipocytes, also within the focal infiltrates. In conclusion, adipocyte development seems to be more prominent in the SG of pSS patients, where adipose tissue replacement is also evident. Whether this is due to disease progression, or the repair process, remains to be investigated. Detection of IL17 positive adipocytes in the target organ suggests their involvement in immune reactions.

Entities:  

Keywords:  Sjögren’s syndrome; adipocytes; interleukin 10; interleukin 17; interleukin 6

Mesh:

Substances:

Year:  2018        PMID: 29504848     DOI: 10.1080/08916934.2018.1446525

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

Review 1.  The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Authors:  Harini Bagavant; Aleksandra Michrowska; Umesh S Deshmukh
Journal:  Autoimmun Rev       Date:  2020-10-22       Impact factor: 9.754

2.  Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.

Authors:  Sara S McCoy; Maxwell Parker; Ilya Gurevic; Rahul Das; Andrea Pennati; Jacques Galipeau
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046

Review 3.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 4.  Current concepts on Sjögren's syndrome - classification criteria and biomarkers.

Authors:  Roland Jonsson; Karl A Brokstad; Malin V Jonsson; Nicolas Delaleu; Kathrine Skarstein
Journal:  Eur J Oral Sci       Date:  2018-10       Impact factor: 2.612

5.  Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.

Authors:  Lara A Aqrawi; Hilde Kanli Galtung; Eduarda M Guerreiro; Reidun Øvstebø; Bernd Thiede; Tor Paaske Utheim; Xiangjun Chen; Øygunn Aass Utheim; Øyvind Palm; Kathrine Skarstein; Janicke Liaaen Jensen
Journal:  Arthritis Res Ther       Date:  2019-07-31       Impact factor: 5.156

6.  Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study.

Authors:  B Tashbayev; T Garen; Ø Palm; X Chen; B B Herlofson; A Young; L H Hove; M Rykke; P B Singh; L A Aqrawi; Ø A Utheim; T P Utheim; J L Jensen
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

Review 7.  Recent Advances of Salivary Gland Biopsy in Sjögren's Syndrome.

Authors:  Rui Liao; Hai-Tao Yang; Heng Li; Li-Xiong Liu; Kai Li; Jing-Jing Li; Jie Liang; Xiao-Ping Hong; Yu-Lan Chen; Dong-Zhou Liu
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques.

Authors:  Xavier Alvarez; Karol Sestak; Siddappa N Byrareddy; Mahesh Mohan
Journal:  Viruses       Date:  2020-07-01       Impact factor: 5.818

9.  Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.

Authors:  Ning Li; Lei Li; Mengyao Wu; Yusi Li; Jie Yang; Yicheng Wu; Haimin Xu; Danyang Luo; Yiming Gao; Xiaochun Fei; Liting Jiang
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

10.  Inflammatory Stratification in Primary Sjögren's Syndrome Reveals Novel Immune Cell Alterations in Patients' Minor Salivary Glands.

Authors:  Tamandeep K Bharaj; Lara A Aqrawi; Siren Fromreide; Roland Jonsson; Johan G Brun; Silke Appel; Kathrine Skarstein
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.